Abbott Announces FDA Approval and U.S. Launch of the TECNIS® Toric Intraocular Lens for Cataract Patients (via PR Newswire)ABBOTT PARK, Ill., April 18, 2013 /PRNewswire/ — Abbott (NYSE: ABT) today announced that the TECNIS® Toric 1-Piece intraocular lens (IOL) has received U.S. Food and Drug Administration (FDA) approval and is launching in the United States for the treatment of cataract patients with pre-existing…
published: April 18, 2013 in: Abbott, Approval/Clearance, Launches / Withdrawals, Ophthalmics